http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3349814-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3082bdc3c9967d59703f4fd64438cdd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe2d8a10ec14cd3998ef9c0637e811b1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
filingDate 2016-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3c68f5589a1e3f80734c28994b9898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_953ff18b8f0b357645b1e35a1d6ede60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef8657f1687da021cb3aeaea999271a
publicationDate 2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3349814-A1
titleOfInvention Non-gelling soluble extracellular matrix with biological activity
abstract Provided are methods for preparing non-gelling, solubilized extracellular matrix (ECM) materials useful as cell growth substrates. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the non-gelling, solubilized ECM composition is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and/or attachment of the device to a patient. In another embodiment, the composition is delivered intraarticularly, intrathecally, intraoccularly, intracranially, and into pleural space.
priorityDate 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226607037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107854

Total number of triples: 36.